Participation of histamine H3 receptors in experimental allergic rhinitis of mice

Journal of Pharmacological Sciences

Volumn 108, Issue 2, 2008, Pages 206-211

  Yokota, Emiko ^a   Kuyama, Shoji ^a   Sugimoto, Yukio ^a   Ogawa, Masami ^b   Kamei, Chiaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Research and Development Division   (Japan)

Author keywords

Allergic rhinitis; Cetirizine; Eosinophil infiltration; Histamine H3 receptor; Histamine H3 receptor agonist

Indexed keywords

HISTAMINE H3 RECEPTOR; 4 (4 METHYL 3 PYRROLIDINYL) 1H IMIDAZOLE; 4-(4-METHYL-3-PYRROLIDINYL)-1H-IMIDAZOLE DIHYDROCHLORIDE; ANTIALLERGIC AGENT; CETIRIZINE; DRUG DERIVATIVE; HISTAMINE AGONIST; HISTAMINE H1 RECEPTOR ANTAGONIST; IMETIT; IMIDAZOLE DERIVATIVE; OVALBUMIN; PYRROLIDINE DERIVATIVE; THIOUREA; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG RECEPTOR BINDING; EOSINOPHIL COUNT; FEMALE; MOUSE; NONHUMAN; NOSE MUCOSA; RECEPTOR INTRINSIC ACTIVITY; SNEEZING; SYMPTOM; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; EOSINOPHIL; IMMUNOLOGY; METABOLISM; NEUTROPHIL CHEMOTAXIS; PERENNIAL RHINITIS; PRURITUS; TIME;

ANIMALS; ANTI-ALLERGIC AGENTS; CETIRIZINE; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EOSINOPHILS; FEMALE; HISTAMINE AGONISTS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; IMIDAZOLES; MICE; MICE, INBRED BALB C; NASAL MUCOSA; OVALBUMIN; PRURITUS; PYRROLIDINES; RECEPTORS, HISTAMINE H3; RHINITIS, ALLERGIC, PERENNIAL; SNEEZING; THIOUREA; TIME FACTORS;

EID: 55549087239     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08164FP     Document Type: Article

References (28)

1. Naclerio RM. Allergic rhinitis. N Engl J Med. 1991;325:860-869.
2. Bachert C. Histamine - a major role in allergy? Clin Exp Allergy. 1998;28 S6:15-19.
3. Howarth PH, Salagean M, Dokic D. Allergic rhinitis: not purely a histamine-related disease. Allergy. 2000;55:7-16.
4. 3) of histamine receptor. Nature. 1983;302:832-837.
5. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, et al. International union of pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev. 1997;49:253-278.
6. 3-receptors on cholinergic nerves in human airways. Eur J Pharmacol. 1989;163:383-386.
7. 3 receptors. Naunyn Schmiedebergs Arch Pharmacol. 1993;348:141-145.
8. 3 receptors. Eur J Pharmacol. 1995;273:83-88.
9. Nakaya M, Takeuchi N, Kondo K. Immunohistochemical localization of histamine receptor subtypes in human inferior turbinates. Ann Otol Rhinol Laryngol. 2004;113:552-557.
10. 3 receptors in scratching behaviour in mast cell-deficient mice. Br J Dermatol. 2003;149:17-22.
11. 3 receptors regulate vascular permeability changes in the skin of mast cell-deficient mice. Int Immunopharmacol. 2003;3:1563-1568.
12. 3 receptor agonist, inhibits central neurogenic vascular inflammation and produces sedation in the guinea pig. J Pharmacol Exp Ther. 1998;287:43-50.
13. α-Methyl histamine safety and efficacy in migraine prophylaxis: phase III study. Can J Neurol Sci. 2006;33:195-199.
14. 3-receptor agonist prodrug. J Pharmacol Exp Ther. 2000;295:219-225.
15. 1-receptor antagonists. Immunopharmacology. 2000;8:1-7.
16. 3 receptor agonist Sch 50971. Arzneimittelforschung. 1998;48:881-888.
17. 3 receptor agonist. J Pharmacol Exp Ther. 1992;263:304-310.
18. van der Goot H, Timmerman H. Selective ligands as tools to study histamine receptors. Eur J Med Chem. 2000;35:5-20.
19. 3 receptors in murine allergic rhinitis. Laryngoscope. 2005;115:1778-1784.
20. 1-receptor antagonist drugs. J Allergy Clin Immunol. 1996;98:S307-S318.
21. 1 receptors. Eur J Pharmacol. 2002;449:287-291.
22. 3 receptor agonist prodrug. J Pharmacol Exp Ther. 1997;281:1085-1094.
23. 3 receptor agonist, on C-fibers, cholinergic fibers and mast cells in rabbit lungs in vitro. Eur J Pharmacol. 1999;371:23-30.
24. Rahman MA, Inoue T, Kamei C. Role of substance P in allergic nasal symptoms in rats. Eur J Pharmacol. 2006;532:155-161.
25. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol. 2000;105:651-663.
26. Klementsson H. Eosinophils and the pathophysiology of allergic rhinitis. Clin Exp Allergy. 1992;22:1058-1064.
27. 4 receptor. J Immunol. 2004;173:2078-2083.
28. 4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol. 2004;142:161-171.